Gadopentetate dimeglumine (CAS 86050-77-3) — formula C28H54GdN5O20, molecular weight 938.0; category organic chemicals.
| CAS Number | 86050-77-3 |
|---|---|
| Molecular Formula | C28H54GdN5O20 |
| Molecular Weight | 938.0 |
| Applications | Uses: Contrast Media, MEDICATION, ... Gadopentetate dimeglumine (Gd-DTPA, Magnevist..) became commercially available in 1988 and is currently marketed in 101 countries. ... Gd-DTPA has been used in more than 45 million magnetic resonance imaging procedures since 1988 and is currently used globally in more than 5 million applications annually., Injectable contrast medium for magnetic resonance imaging (MRI), Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues., Contrast agents, Formulations, Preparations: Magnevist (brand of gadopentetate dimeglumine) injection is the N-methylglucamine salt of the gadolinium complex of diethylenetriamine pentaacetic acid, and is an injectable contrast medium for magnetic resonance imaging (MRI). Magnevist Injection is provided as a sterile, clear, colorless to slightly yellow aqueous solution for intravenous injection. Each mL of Magnevist injection contains 469.01 mg gadopentetate dimeglumine, 0.99 mg meglumine, 0.40 mg diethylenetriamine pentaacetic acid, and water for injection. Magnevist injection contains no antimicrobial preservative. |
| Category | Organic Chemicals |
Documented applications: Uses: Contrast Media, MEDICATION, ... Gadopentetate dimeglumine (Gd-DTPA, Magnevist..) became commercially available in 1988 and is currently marketed in 101 countries. ... Gd-DTPA has been used in more than 45 million magnetic resonance imaging procedures since 1988 and is currently used globally in more than 5 million applications annually., Injectable contrast medium for magnetic resonance imaging (MRI), Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues., Contrast agents, Formulations, Preparations: Magnevist (brand of gadopentetate dimeglumine) injection is the N-methylglucamine salt of the gadolinium complex of diethylenetriamine pentaacetic acid, and is an injectable contrast medium for magnetic resonance imaging (MRI). Magnevist Injection is provided as a sterile, clear, colorless to slightly yellow aqueous solution for intravenous injection. Each mL of Magnevist injection contains 469.01 mg gadopentetate dimeglumine, 0.99 mg meglumine, 0.40 mg diethylenetriamine pentaacetic acid, and water for injection. Magnevist injection contains no antimicrobial preservative..
Gadopentetate dimeglumine is a carbon-based organic compound with CAS registry number 86050-77-3 and molecular formula C28H54GdN5O20 (molecular weight 938.0), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 86050-77-3
Its molecular formula C28H54GdN5O20 comprises 28 C, 54 H, 1 Gd, 5 N, 20 O atoms.
Also known as: Gadopentetate dimeglumine · 钆喷酸二葡胺
Category: organic chemicals
The CAS registry number of Gadopentetate dimeglumine is 86050-77-3.
Molecular formula C28H54GdN5O20, molecular weight 938.0.
It is also registered under: Gadopentetate dimeglumine, 钆喷酸二葡胺.
Recorded applications: Uses: Contrast Media, MEDICATION, ... Gadopentetate dimeglumine (Gd-DTPA, Magnevist..) became commercially available in 1988 and is currently marketed in 101 countries. ... Gd-DTPA has been used in more than 45 million magnetic resonance imaging procedures since 1988 and is currently used globally in more than 5 million applications annually., Injectable contrast medium for magnetic resonance imaging (MRI), Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues., Contrast agents, Formulations, Preparations: Magnevist (brand of gadopentetate dimeglumine) injection is the N-methylglucamine salt of the gadolinium complex of diethylenetriamine pentaacetic acid, and is an injectable contrast medium for magnetic resonance imaging (MRI). Magnevist Injection is provided as a sterile, clear, colorless to slightly yellow aqueous solution for intravenous injection. Each mL of Magnevist injection contains 469.01 mg gadopentetate dimeglumine, 0.99 mg meglumine, 0.40 mg diethylenetriamine pentaacetic acid, and water for injection. Magnevist injection contains no antimicrobial preservative..
Category: Organic Chemicals.
Independent reference data for Gadopentetate dimeglumine (CAS 86050-77-3), compiled from public chemistry databases.
| CAS Registry Number | 86050-77-3 |
|---|---|
| PubChem CID | 55466 |
| Molecular formula | C28H54GdN5O20 |
| IUPAC name | 2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);bis((2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol) |
| UNII (FDA) | RH248G8V27 |
| Molecular Weight | 938.0 |
|---|---|
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 25 |
| Rotatable Bond Count | 25 |
| Exact Mass | 938.26033 |
| Monoisotopic Mass | 938.26033 |
| Topological Polar Surface Area | 431 |
| Heavy Atom Count | 54 |
Magnevist; Gadopentetic acid dimeglumine salt; Dimeglumine-gadolinium-dtpa; CHEBI:31797; DTXSID70235367; Diethylenetriaminepentaacetic acid dimeglumine salt gadolinium chelate; Diethylenetriaminepenta-acetic Acid, Gadolinium; Magnevist Enteral; Magnograf Enteral; DTPA, Gadolinium; Gd DTPA; RefChem:57348; Dimeglumine, Gadopentetate; Gadolinium DTPA Dimeglumine; Dimeglumine, Gadolinium DTPA; DTXCID70157858
Gadopentetate dimeglumine · CAS 86050-77-3 · C28H54GdN5O20. UNII RH248G8V27.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 钆喷酸二葡胺